KOR
ENG
Company
Greeting
About Us
Overview
Mission & Vision
History
News
Business
Major Business
Product
All-products
Prescription Drugs
Over-the-Counter Drugs
In Vitro Diagnostic Medical Devices
Life Science Products
Medical Devices
Healthcare Products
Partnering
Introduction
Product Licensing
Contract Manufacturing & QC
R&D
Introduction
Pipeline
Sustainability
Overview
Environment
Social
Governance
Governance structure
Ethical Management
Investor
Financial Information
지금 무엇을 찾으시나요?
추천검색어
Prescription Drugs
Over-the-Conunter Drugs
In Vitro Diagnostic Medical Devices
Life Science Products
Medical Devices
Healthcare Products
한독은 인류의 건강과
삶의 질을 위해 노력합니다.
한독과 함께 변화하는 삶
일상건강에서 만나보세요
Company
Greeting
About Us
Overview
Mission & Vision
History
News
Business
Major Business
Product
All-products
Prescription Drugs
Over-the-Counter Drugs
In Vitro Diagnostic Medical Devices
Life Science Products
Medical Devices
Healthcare Products
Partnering
Introduction
Product Licensing
Contract Manufacturing & QC
R&D
Introduction
Pipeline
Sustainability
Overview
Environment
Social
Governance
Governance structure
Ethical Management
Investor
Financial Information
KR
EN
Company
Greeting
About Us
Overview
Mission & Vision
History
News
Business
Major Business
Product
All-products
Prescription Drugs
Over-the-Counter Drugs
In Vitro Diagnostic Medical Devices
Life Science Products
Medical Devices
Healthcare Products
Partnering
Introduction
Product Licensing
Contract Manufacturing & QC
R&D
Introduction
Pipeline
Sustainability
Overview
Environment
Social
Governance
Governance structure
Ethical Management
Investor
Financial Information
궁금한 부분이 있으신가요?
CONTACT
한독과 함께 변화하는 삶
일상건강
Handok Affiliate Rezolute's Congenital Hyperinsulinism Treatment RZ358 Designated as a Breakthrough Therapy by the FDA
Handok Begins Domestic Sales of Hyperlipidemia Treatment Lipidil from Korea Abbott
Handok Affiliate Rezolute's RZ358 Designated as an Orphan Drug by the FDA for the Treatment of Hypoglycemia Due to Tumor-Induced Hyperinsulinism
Handok Hosts 70th Anniversary R&D Symposium on Open Innovation
Handok's Affiliate Rezolute Advances Development of Congenital Hyperinsulinism Treatment (RZ358), Confirming Safety and Proceeding with Phase 3 Trials in the U.S. Without Age Restrictions
Handok's Non-Small Cell Lung Cancer Drug Development Project Selected for Ministry of Trade, Industry and Energy's Global Industry Technology Cooperation Center Program
프레스룸
총
1036
개의 소식들이 있습니다
한독의 관계사 레졸루트, 선천성 고인슐린증 치료제 RZ358 3상 임상 sunRIZE 연구 업데이트 발표
2025.02.05
[매일경제] “설 연휴 일단 먹고 보자”…국내 1등 소화제는? [MK약국]
2025.01.25
[매일경제TV] 2030도 '혈당관리'한다?…수시로 혈당 변화 확인해야
2025.01.17
한독 관계사 레졸루트의 선천성 고인슐린증 치료제 RZ358, FDA로부터 혁신치료제로 지정 받아
2025.01.08
한독, 설 맞이 건강 선물 기획전 진행
2025.01.07
[매일경제] '우리집 주치의' 혈당·혈압 측정기 초고령시대 의료비 부담 덜어주나
2025.01.06
한독, 한국애보트의 고지혈증 치료제 리피딜 국내 판매 나서
2025.01.02
[데일리팜] 겨울 칼바람, 사랑의 연탄배달로 체온 나눠요
2024.12.26
한독, 크론병 환자용 영양식, ‘엘리멘탈028 엑스트라’ 바나나향 출시
2024.12.19
PREV
1
2
3
4
5
6
7
8
9
10
NEXT